A NUMBER OF ESSENTIAL FUNCTIONS are provided by the epithelial lining of the gastrointestinal (GI) tract. In addition to nutrient digestion/absorption and immune surveillance roles, the gut epithelium also secretes electrolytes; it is this vectorial electrolyte secretion that establishes a driving force for directed water movement. Excess water in the lumen can lead to diarrhea (essentially a protective process), which if recurrent or prolonged may result in dehydration and even death. Given the association of GI epithelia with the enteric nervous system, neighboring enteroendocrine cells, and the luminal contents, it is not surprising that nervous and endocrine input as well as bacteria and/or their products constitute the major regulators of epithelial function. Recent literature, however, particularly from in vitro studies, has shown that immune mediators including cytokines can also modify epithelial function (24) .
Growth factors are cytokines that have been shown to have both mitogenic and nonmitogenic effects. Specifically, in terms of ion transport, treatment of colonic epithelial cell lines with transforming growth factor (TGF)-␣ or epidermal growth factor (EGF) resulted in decreased secretory responses to stimulants of chloride secretion (6, 39) . TGF-␤ is a multifunctional cytokine, the bioactivity of which can be grouped into three main properties: 1) regulation of cell growth and proliferation, 2) immunomodulation, and 3) stimulation of wound repair (epithelial restitution). Studies have shown that TGF-␤ is upregulated in many diseases, including inflammatory bowel disease (IBD) (2) , an enteropathy often characterized by perturbed water movement. Given that altered epithelial electrolyte transport can lead to aberrant water balance in the gut, that other growth factors have been shown to affect this process, and that TGF-␤ is upregulated during enteric disease, the primary aim of this study was to determine the effect of TGF-␤ on epithelial ion transport function.
Using monolayers of the human T84 or HT-29 colonic epithelial cell lines as model epithelia, we have shown that exposure to TGF-␤ leads to a ϳ30% decrease in epithelial secretory responses to stimuli that initiate cAMP-dependent Cl Ϫ secretion. This disruption of normal electrolyte transport events is temporally distinct from the ability of TGF-␤ to increase epithelial barrier function and can be restored by treatment with SB-203580, an inhibitor of the p38 mitogen activated protein kinase (MAPK) signaling pathway.
MATERIALS AND METHODS
Cell culture. The human colonic adenocarcinoma-derived T84 epithelial cell line was maintained in media containing equal volumes of Dulbecco's modified Eagle's medium (DMEM) and Ham's F-12 medium, supplemented with 10% (vol/vol) fetal calf serum, 1.5% (vol/vol) HEPES, and 2% (vol/vol) penicillin-streptomycin (all from Life Technologies, Grand Island, NY) at 37°C, 5% CO 2. The HT-29cl.19A cell line (HT-29; a kind gift from Dr. J. A. Groot, University of Amsterdam) was maintained in DMEM supplemented with 5% (vol/vol) fetal calf serum, 0.1% vol/vol L-glutamine, 2% (vol/vol) penicillin-streptomycin, and 5% (vol/vol) sodium bicarbonate. Cells were seeded onto semipermeable filter supports (0.4-m pore size; Costar, Cambridge, MA) with a surface area of 1 cm 2 (10 6 cells) for physiological assessment and grown to confluence as determined by transepithelial resistance (TER; minimum 6 days growth).
Physiological assessment studies. Recombinant human TGF-␤ (R&D Systems, Minneapolis, MN) was added to the basolateral compartment of the semipermeable filter supports at concentrations of 0.1, 1, 10, or 100 ng/ml. The basolateral surface of T84 cells was exposed to TGF-␤ for 4, 8, 16, 24 , and 72 h, at which point cells were mounted in specialized Ussing chambers (Precision Instrument Design, Tahoe City, CA) under voltage-clamped conditions as previously described (25) , and short-circuit current (I sc) responses to known stimuli of Cl Ϫ secretion were measured. In other studies, T84 monolayers were exposed to TGF-␤ for 15 min, then rinsed twice in fresh medium, and Isc responses examined 16 h later. Comparative studies examined Isc responses to EGF (10 or 100 ng/ml; R&D Systems) after 16 h of exposure. Acute experiments exposed T84 cells to TGF-␤ for 30 min (1 or 10 ng/ml) while mounted in the Ussing chambers, followed by measurement of Isc responses. In all experiments, baseline Isc was obtained after 10 min of equilibration. Stimulated Cl Ϫ secretion was induced by forskolin (10 Ϫ5 M), vasoactive intestinal peptide (VIP, 10 Ϫ7 M), cholera toxin (10 g/ml), and dibutyryl cAMP (200 M) (all from Sigma Chemical, St. Louis, MO), and the maximal change in Isc (⌬Isc) was recorded. These secretagogues were chosen because of their known ability to elicit Cl Ϫ secretion via raising intracellular cAMP (13, 23, 44) . TER (in ⍀/cm 2 ) of the T84 monolayers was recorded with chopstick electrodes and a voltmeter (Millipore, Bedford, MA) as a measure of paracellular permeability.
Adenoviral infection. Twenty-four hours after seeding (10 6 cells/ml on semipermeable filter supports), T84 cells were infected with replication-deficient adenovirus constructs encoding active TGF-␤ [Ad-TGF␤ (35) ] at a multiplicity of infection (MOI) of 10, 20, or 50 virus particles/cell. Sixteen hours later, T84 cells were rinsed twice with medium to remove any residual virus and cultured for 6 days, whereupon they were mounted in Ussing chambers for analysis of secretory responsiveness to forskolin. Changes in barrier function were monitored daily throughout the 6-day postinfection period by recording TER. Epithelia infected with either 1) the deletion variant (empty vector) of the replication-deficient adenovirus [Addelete (16)] or 2) adenovirus encoding latent TGF-␤ [Adlatent TGF␤ (47) ] were used as additional controls for these experiments. Infectivity of the adenovirus was verified in T84 cells by using virus expressing the marker genes ␤-galactosidase or luciferase (27) . Finally, synthesis of the active form of TGF-␤ from Ad-TGF␤-infected cells and noninfected control epithelia was determined by the presence of TGF-␤ in the media at 24-h intervals postinfection (24-120 h) using ELISA (R&D Systems). When the experiments were completed, epithelial cells were trypsinized off the filter supports and viability was assessed with the trypan blue exclusion technique.
Pharmacological inhibition of intracellular signaling.
Physiological assessment experiments were conducted by using a single dose (10 ng/ml) and time (16 (42)]. TGF-␤ was subsequently added to the basal compartment of the culture well (inhibitor not washed out) and, after a defined incubation time, the monolayers were mounted in Ussing chambers and I sc responses to forskolin were recorded. Pharmacological inhibition of the p38 MAPK signaling cascade in HT-29 cells was accomplished by pretreating monolayers with SB-203580 for 30 min (0.1-50 M), subsequently followed by TGF-␤ application (100 ng/ml, 24 h).
Statistical and data analysis. Data are normalized to timematched controls (i.e., percentage of control response) and are presented as means Ϯ SE. Data were analyzed using one-way ANOVA, and P Ͻ 0.05 was accepted as the level of statistical significance.
RESULTS

TGF-␤ reduces I sc responses to cAMP secretagogues.
Treatment with TGF-␤ (0.1-100 ng/ml, 4-72 h) did not significantly affect baseline I sc compared with naive time-matched controls [0.17 Ϯ 0.17 vs. 0.33 Ϯ 0.33 A/cm 2 for control and TGF-␤-treated (10 ng/ml, 16h), respectively, n ϭ 6 monolayers from a representative experiment]. Addition of TGF-␤ to the Ussing chamber for 30 min (0.1, 1, 10 ng/ml) had no effect on epithelial baseline I sc or ⌬I sc evoked by forskolin (data not shown). Treatment with TGF-␤ for 16 h did, however, cause a statistically significant decrease in I sc responses to forskolin; this was evident with Ն1 ng/ml (data not shown). Figure 1 shows that T84 cells exposed to TGF-␤ (10 ng/ml) for 16 or 24 h demonstrated a statistically significant decrease in forskolin-induced I sc responses of ϳ30% compared with controls (P Ͻ 0.0001). This reduced responsiveness to forskolin was further enhanced by 72 h post-TGF-␤ treatment, being on average only 50% of the magnitude of the response observed in time-matched control monolayers (P Ͻ 0.05 compared with 16 and 24 h of TGF-␤ exposure). After 72 h of TGF-␤ treatment, there was a significant increase in TER (1,405 Ϯ 254 ⍀/cm 2 compared with control at 846 Ϯ 204 ⍀/cm 2 , P Ͻ 0.05, n ϭ 9-12 monolayers) that was not observed with shorter TGF-␤ exposure periods. In "washout" experiments, cells exposed to TGF-␤ (10 ng/ml) for 16 h and subsequently rinsed free of TGF-␤ also displayed a similar decrease in I sc responses to forskolin at 72 h posttreatment (40.6 Ϯ 1.7% of control response, P Ͻ 0.0001, n ϭ 3 monolayers), comparable to those seen after 72 h of persistent TGF-␤ exposure (49.3 Ϯ 7.5% of control responses, P Ͻ 0.0001, n ϭ 9 monolayers). This washout treatment also resulted in increased TER (1,598 Ϯ 48 ⍀/cm 2 vs. controls at 847 Ϯ 20 ⍀/cm 2 , P Ͻ 0.001, n ϭ 3). T84 cells exposed to TGF-␤ for 16 h at the highest dose used (i.e., 100 ng/ml) displayed a ϳ30% decrease in forskolin-induced increases in I sc , which was not statistically different from the inhibition of I sc observed with lower doses of cytokine (i.e., 10 ng/ml). Furthermore, additional washout experiments revealed that exposure to TGF-␤ for 15 min was sufficient to induce diminished responsiveness to forskolin upon examination 16 h later (untreated controls 37.3 Ϯ 4 vs. TGF-␤-treated cells 17 Ϯ 2.1 A/cm 2 . P Ͻ 0.001, n ϭ 6-7 monolayers), in this case a 55% reduction in ⌬I sc .
TGF-␤ treatment (10 ng/ml, 16 h) also resulted in a significant diminution of epithelial responsiveness to cAMP-driven Cl Ϫ secretion initiated by VIP and cholera toxin (Fig. 2) . Similarly, cells exposed to TGF-␤ displayed reduced ⌬I sc responses to the cell-permeant cAMP analog, dibutyryl cAMP (Fig. 2) . In contrast to the effects of TGF-␤ on I sc responses, T84 monolayers treated with EGF for 16 h (10 or 100 ng/ml) displayed I sc responses to forskolin that were not different from controls (Table 1) .
In additional experiments, HT-29 epithelial cells treated with TGF-␤ (100 ng/ml, 72 h) displayed reduced I sc responses to forskolin (control 118.7 Ϯ 23.7 vs. TGF-␤-treated 64.3 Ϯ 12.3 A/cm 2 , P Ͻ 0.05, n ϭ 3 monolayers). After 72 h of exposure, TGF-␤-treated HT-29 monolayers also exhibited a small, but significant, increase in TER compared with controls (control 287.7 Ϯ 6.8 vs. TGF-␤ 302.0 Ϯ 3.1 ⍀/cm 2 , P Ͻ 0.05, n ϭ 3 monolayers).
Exposure to TGF-␤1 delivered via adenoviral gene transfer causes decreased forskolin responsiveness. We sought to determine what effect chronic exposure to TGF-␤ would have on epithelial function using adenoviral gene transfer of the biologically active form of TGF-␤. Cell infectivity was verified by use of adenoviral vectors encoding marker genes (Fig. 3A) . Cells infected with the highest dose of virus (50 MOI) displayed no significant decrease in viability, as determined by the trypan blue exclusion technique (data not shown), and exhibited increased TGF-␤ production compared with uninfected controls (e.g., 912.2 Ϯ 202.4 pg/ml TGF-␤ in supernatants collected 72 h after infection with Ad-TGF␤ vs. 217.9 Ϯ 8.5 pg/ml in supernatants of naive controls, P Ͻ 0.05, n ϭ 3). Assessment of I sc responses to forskolin 6 days post-Ad-TGF␤ infection revealed a statistically significant decrease in secretory responsiveness compared with naive controls and T84 cells infected with Ad-delete or Ad-latent TGF␤ (Fig. 3B) . In addition, Ad-TGF␤ infection resulted in a statistically significant increase in TER by the end of the 6-day (144 h) postinfection period (Fig.  3C) , which was first apparent 72 h postinfection ( (Fig. 4) , whereas similarly treated T84 monolayers resulted in a significant, but only partial, improvement in I sc responses to forskolin (Table 2 ). Other signaling pathways in T84 epithelial cells did not appear to contribute to the diminished I sc , because pretreatment Values are means Ϯ SE (in A/cm 2 ). Isc, short-circuit current; n, no. of monolayers.
with the JNK inhibitor (SP-600125), ERK1/2 pathway inhibitor (PD-98059), and the PI 3-K inhibitor (LY-294002) did not inhibit the observed effect of TGF-␤ on ion transport; in fact, exposure to PD-98059 or LY-294002 alone caused a significant decrease in I sc responses to forskolin ϳ16 h later (Table 2) .
DISCUSSION
TGF-␤ is a multifunctional peptide that affects cell proliferation and differentiation and has immunosuppressive properties. Using human enteric epithelial cell lines, we have shown that 1) exposure to TGF-␤ significantly decreases cAMP-driven Cl Ϫ secretion; 2) this effect can be blocked by an inhibitor of p38 MAPK but not by pharmacological inhibitors of JNK, ERK1/2 MAPK, or PI 3-K activity; and 3) the increased barrier function caused by TGF-␤ is temporally distinct (i.e., delayed) from the altered ion transport characteristics of the treated epithelium.
Ion transport is an important element of gut homeostasis. As the driving force for water movement, it facilitates surface hydration, which, if dysregulated, can result in debilitating diarrhea or constipation. TGF-␤ had no effect on tonic epithelial ion transport (i.e., baseline I sc ) but significantly reduced secretory responses to three cAMP-dependent secretagogues that operate via different mechanisms. This effect likely lies downstream of cAMP generation, because TGF-␤-treated cells stimulated with dibutyryl cAMP displayed similarly reduced I sc events. The responses to forskolin, VIP, cholera toxin, and dibutyryl cAMP were all reduced by a similar magnitude (i.e., ϳ30%), suggesting that although TGF-␤ can dampen cAMPdriven Cl Ϫ secretion, the pathophysiology that would be associated with total blockade of Cl Ϫ secretion is avoided. The inhibition of secretory responsiveness required a minimum of 1 ng/ml TGF-␤ and was statistically significant 16 h posttreatment; however, constant exposure to TGF-␤ was not essential, because a 15-min exposure resulted in reduced ⌬I sc to forskolin 16 h later. Higher doses of TGF-␤ did not affect the time required to observe a reduced ⌬I sc to forskolin, and they did not affect the magnitude of the response. This lack of a dose response has been noted for TGF-␣ inhibition of bradykinin-induced ⌬I sc in HCA-7 colonocytes, although in this instance the I sc responses were reduced by 6 h posttreatment (6) .
The effects of recombinant TGF-␤ were reproduced in epithelia infected with adenovirus encoding the gene for the active form of TGF-␤; diminished ⌬I sc to forskolin were apparent 144 h postinfection (i.e., end of the experiment). However, unlike other growth factors, such as EGF and IGF, which induce acute effects on epithelial ⌬I sc (39, 11) , TGF-␤ when added to T84 monolayers in Ussing chambers for 30 min had no effect on subsequent forskolin-evoked ⌬I sc . Thus TGF-␤ can be added to the list of cytokines that directly modulate epithelial ion transport (reviewed in Ref. 24 ). In addition, the effect of TGF-␤ is set apart from those of other growth factors that rapidly affect ion transport; rather, the TGF-␤ effect is reminiscent of IFN-␥ or IL-4 diminution of epithelial secretory responsiveness, which typically requires 24 h or longer to become apparent (1, 10) .
Upon identifying that TGF-␤ exerts an effect on epithelial ion transport, a number of mechanistic issues arose. One option was to investigate the physiological changes mediated by TGF-␤, such as the possible change in amount, location, or activity of the apical Cl Ϫ channel, CFTR. Indeed, growth factor regulation of specific ion channels (3, 34) and cytokine modulation of CFTR gene expression have been reported (7, 9, 30) . Alternatively, the TGF-␤ signaling pathway leading to the decreased secretory response could be addressed. Data from many cell types show that TGF-␤ binding to its surface receptor causes mobilization of classic MAPKs and a unique series of molecules designated SMADs, and these signaling cascades regulate specific aspects of the biological effects of TGF-␤ (29, 37, 41, 46) . Little is known, however, of the TGF-␤ signaling pathways in epithelia in general (36) , with a distinct lack of data relevant to enteric epithelial cells.
Using a pharmacological approach, we found that the TGF-␤ effects on ion transport were reduced in two cell lines by pretreatment with the established inhibitor of the p38 MAPK pathway, SB-203580. This is the first time p38 MAPK has been implicated in governing a TGF-␤ function in gut epithelia, and these findings are complementary to a recent report showing that hyperosmolar stress-induced reduction in colonic CFTR mRNA was blocked by inhibition of p38 MAPK activity (5). Whereas low-dose SB-203580 (i.e., 1 M) completely restored the TGF-␤-induced diminished ion transport events in HT-29 cells, higher doses of the pharmacological inhibitor only partially corrected the defect in T84 epithelia. This finding indicates cell linespecific differences and, in the case of T84 cells, suggests either reduced sensitivity to SB-203580 or that other signaling pathways participate in the TGF-␤ effect. Thus we adopted the same pharmacological approach to assess the putative involvement of other signaling molecules in TGF-␤ modulation of ion transport. JNK is likely activated in tandem with p38 MAPK in response to TGF-␤ (22, 43) and can affect the Na ϩ -K ϩ -2Cl Ϫ transporter (19) . Interference with the activity of this transporter would impact on apical Cl Ϫ secretion events. Furthermore, high-dose SB-203580 (i.e., 10-20 M) may inhibit JNK activity (45) , yet use of a reputedly specific inhibitor of JNK activity did not ameliorate the TGF-␤-induced diminution of T84 ⌬I sc to forskolin. ERK, the third member of the MAPK family, is mobilized in a variety of cell types by TGF-␤ (14, 15, 28) : pharmacological inhibition of MEK, the enzyme upstream of ERK, did not affect the decreased ⌬I sc induced by TGF-␤. Finally, use of an established inhibitor of PI 3-K activity excluded the involvement of this ubiquitous signaling molecule in the TGF-␤-induced perturbation of cAMP-driven Cl Ϫ secretion. The latter observation contrasts with the diminished carbachol-induced increases in I sc in T84 cells caused by EGF that are PI 3-K sensitive (40) . In this context, we observed that TGF-␤ did not consistently alter carbachol-elicited increases in I sc in T84 or HT-29 epithelia (personal observation).
Exposure to the MEK and PI 3-K inhibitors alone reduced T84 ⌬I sc to forskolin ( Table 2 ), suggesting that longer inhibition of ubiquitous signaling pathways may affect multiple energy-dependent processes such as epithelial ion transport. The inhibition of forskolininduced ⌬I sc by LY-294002 appears to contradict the work of Dickson et al. (12) . The discrepancy may be due to the fact that in the latter study, the epithelium was exposed to LY-294002 in Ussing chambers for Յ30 min and I sc responses were immediately assessed. Indeed, when those investigators inhibited PI 3-K via wortmannin for 24 h, they observed an ϳ50% decrease in forskolin-stimulated I sc , which is compatible with the data in the current study.
Agent specificity must be considered in any pharmacological study. Although accepted as a specific p38 MAPK inhibitor, SB-203580 has recently been shown to block the activity of ALK5, a kinase that phosphorylates SMAD3 (21) . Thus involvement of SMAD3 in TGF-␤ inhibition of ⌬I sc to forskolin is a possibility. We have been unable to convincingly and consistently show increased amounts of phosphorylated p38 MAPK in nuclear or whole cell extracts of serum-starved TGF-␤-treated epithelial cells, or elevated p38 MAPK activity (data not shown). This may be due to 1) the relatively high constitutive phospho-p38 MAPK found in control extracts; 2) the possibility that there may in fact be only very subtle increases in activated p38 MAPK, because TGF-␤ causes only a partial ablation of the I sc response; or 3) the TGF-␤ effect on ion transport is via a specific p38 MAPK isoform (i.e., ␣, ␤, ␥, or ␦), the increases of which are masked by constitutive expression of the other isoforms. Indeed, in light of the data from Laping et al. (21) , a finding of increased phospho-p38 MAPK in TGF-␤-treated epithelia would be suggestive, but not unequivocal proof, of involvement of this enzyme in the altered ion transport. Thus, although we have ruled out JNK, ERK, and PI 3-K, definitive statements regarding the intracellular signals that mediate the TGF-␤ effect on enteric epithelial ion transport require the development of p38 MAPK and SMAD3 knockout (and preferably inducible knockout) cell lines suitable for the analysis of vectorial ion transport.
Recombinant or adenovirally delivered TGF-␤ was shown to increase TER, an accepted index of the paracellular permeability pathway. This finding is in accordance with studies where TGF-␤ was shown to increase epithelial barrier function and/or preserve barrier integrity compromised by inflammatory cytokines (26, 31, 32) . Intriguingly, we found that the effects of TGF-␤ on barrier function were temporally distinct from those on ion transport: TER was, unlike I sc , unaltered by 16-24 h post-TGF-␤ treatment. This divergence in the timing of TGF-␤ effects on two of the primary roles of the enteric epithelium implies utilization of different or additional signaling pathways in the modulation of epithelial barrier and ion transport. Research directed toward understanding the structural basis for the TGF-␤-induced increased TER, the signaling events underlying this process, and definition of the mechanism(s) responsible for the temporal separation of enhancement of the epithelial barrier and diminished cAMP-driven Cl Ϫ secretion are required. As noted, TGF-␤ can antagonize IFN-␥-mediated disruption of the barrier function of T84 monolayers (32) . Because IFN-␥ can reduce TER within 24 h of exposure and TGF-␤-induced increases in TER are not apparent at this time (i.e., 24 h), it is suggested that the TGF-␤ inhibition of IFN-␥-induced decreases in TER occurs via a distinct mechanism, that is, inhibition of the IFN-␥ signaling cascade. The reciprocal event (i.e., IFN-␥ interference of TGF-␤ SMAD signaling) has been shown (38) .
In conclusion, irrespective of the intracellular signaling mechanism, exposure of model gut epithelia to TGF-␤ not only led to the expected increase in TER (i.e., at 72 h posttreatment) but also resulted in diminished responsiveness to cAMP-dependent secretagogues 16 h posttreatment. Prolonged exposure to TGF-␤ (using adenoviral vectors encoding the gene for the active form of TGF-␤) maintained the Cl Ϫ secretion abnormality. The temporal separation of TGF-␤ modulation of epithelial ion transport and barrier functions adds to our appreciation of the complexity and spectrum of biological activities coordinated by this pleiotropic cytokine. Finally, we speculate that in addition to its ability to maintain or enhance epithelial barrier function, TGF-␤ may reduce pathophysiological complications resulting from excess water movement into the gut lumen by limiting cAMP-driven Cl Ϫ secretion.
We thank J. Lu and I. Gunawan for technical assistance. 
